论文部分内容阅读
目的:评价专注达治疗儿童注意缺陷多动障碍的疗效及安全性。方法:采用前瞻、开放性、自身对照方法,对2005年7月~2006年2月就诊于该院门诊的6~14岁29例患儿采用专注达治疗6周,分别于治疗2周末、4周末及6周末通过专业量表测量、临床晤谈、体格检查、专人定期随访方式进行临床疗效和安全性评定。结果:治疗总有效率为75.9%,把各项因子于2周末、4周末、6周末与治疗前进行比较均有下降。结论:专注达是一种安全有效的治疗儿童注意缺陷多动障碍的药物。
PURPOSE: To evaluate the efficacy and safety of a focus on treatment of attention deficit hyperactivity disorder in children. Methods: A prospective, open and self-control study was performed on 29 children aged 6-14 years old treated in our hospital from July 2005 to February 2006 for 6 weeks. At the end of 2 weeks of treatment, 4 Weekend and 6 weeks through the professional scale measurement, clinical interviews, physical examination, regular follow-up of clinical efficacy and safety assessment. Results: The total effective rate of treatment was 75.9%. The factors decreased at the end of 2 weeks, 4 weeks and 6 weeks compared with before treatment. CONCLUSION: Focus is a safe and effective drug for the treatment of children with attention-deficit hyperactivity disorder.